Company Lookup
عربي
 
 

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $2.70 million in 9M 2021

2021-11-01

According to financial statements of Jerusalem Pharmaceuticals JPH for the first nine months of 2021, Net profit after tax of the period reached 2,698,334 USD Compared with Net profit after tax 2,602,689 USD for 2020, a net increase in profit of 3.67%.Total assets of the company reached 81,388,899 USD compared with total assets of 77,707,289 USD at the end of year 2020, a net increase of 4.74%.Total liabilities of the company reached 18,693,217 USD compared with total liabilities of 16,066,093 USD at the end of year 2020, a net increase of 16.35%. Net ownership equity of the company reached 62,695,682 USD (Including Non-Controlling Interests of 2,208,282 USD) compared with total owner equity of 61,641,196 USD (Including Non-Controlling Interests of 2,318,984 USD) at the end of year 2020, a net increase of 1.71%.

 


 

2024-04-18
Al-Quds Index increases amid growing in the dividends proposals momentum for 2023

2024-04-15
TPIC proposes distributing 5% stocks dividends for the year 2023

2024-04-14
PIBC recommends distributing 2.5641% stocks dividends for the year 2023

2024-04-14
ABRAJ recommends converting the company from public shareholding to private shareholding

2024-04-14
NCI recommends distributing 12% cash dividends for the year 2023

2024-04-04
TRUST approves distributing 10% cash dividends for the year 2023

2024-04-04
Al-Quds Index stands-still with the start of April

2024-04-03
TIC approves distributing 15% cash dividends for the year 2023

2024-04-01
NSC recommends distributing 7% stocks dividends for the year 2023

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403